NYLI Candriam International Equity ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
NYLI Candriam International Equity ETF IQSI
Morningstar’s Analysis IQSI
Will IQSI outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the IQSI management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of IQSI’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 19.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
ASML Holding NV | 5.11 | 13M | Technology |
Novartis AG Registered Shares | 1.97 | 5M | Healthcare |
Roche Holding AG Ordinary Shares new | 1.96 | 5M | Healthcare |
AstraZeneca PLC | 1.88 | 5M | Healthcare |
Nestle SA | 1.78 | 5M | Consumer Defensive |
Siemens AG | 1.68 | 4M | Industrials |
Commonwealth Bank of Australia | 1.34 | 4M | Financial Services |
Tokyo Electron Ltd | 1.32 | 3M | Technology |
Toyota Motor Corp | 1.28 | 3M | Consumer Cyclical |
Schneider Electric SE | 1.24 | 3M | Industrials |
United States